These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15806138)
1. Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I Lab Invest; 2005 Jun; 85(6):768-79. PubMed ID: 15806138 [TBL] [Abstract][Full Text] [Related]
2. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221 [TBL] [Abstract][Full Text] [Related]
3. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320 [TBL] [Abstract][Full Text] [Related]
4. Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I Int J Cancer; 2006 Nov; 119(10):2294-303. PubMed ID: 16858682 [TBL] [Abstract][Full Text] [Related]
5. Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas. Saegusa M; Hashimura M; Kuwata T Lab Invest; 2012 Apr; 92(4):511-21. PubMed ID: 22231735 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667 [TBL] [Abstract][Full Text] [Related]
7. Regulation of beta -catenin transformation by the p300 transcriptional coactivator. Sun Y; Kolligs FT; Hottiger MO; Mosavin R; Fearon ER; Nabel GJ Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12613-8. PubMed ID: 11050151 [TBL] [Abstract][Full Text] [Related]
8. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. Saegusa M; Okayasu I J Pathol; 2001 May; 194(1):59-67. PubMed ID: 11329142 [TBL] [Abstract][Full Text] [Related]
9. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways. Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219 [TBL] [Abstract][Full Text] [Related]
10. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378 [TBL] [Abstract][Full Text] [Related]
12. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors. Kennell JA; O'Leary EE; Gummow BM; Hammer GD; MacDougald OA Mol Cell Biol; 2003 Aug; 23(15):5366-75. PubMed ID: 12861022 [TBL] [Abstract][Full Text] [Related]
13. Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. Hecht A; Stemmler MP J Biol Chem; 2003 Feb; 278(6):3776-85. PubMed ID: 12446687 [TBL] [Abstract][Full Text] [Related]
14. The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway. Ghiselli G; Coffee N; Munnery CE; Koratkar R; Siracusa LD J Biol Chem; 2003 May; 278(22):20259-67. PubMed ID: 12651860 [TBL] [Abstract][Full Text] [Related]
15. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Tutter AV; Fryer CJ; Jones KA Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639 [TBL] [Abstract][Full Text] [Related]
16. p73beta, a variant of p73, enhances Wnt/beta-catenin signaling in Saos-2 cells. Ueda Y; Hijikata M; Takagi S; Takada R; Takada S; Chiba T; Shimotohno K Biochem Biophys Res Commun; 2001 May; 283(2):327-33. PubMed ID: 11327702 [TBL] [Abstract][Full Text] [Related]
18. Pin1 acts as a modulator of cell proliferation through alteration in NF-κB but not β-catenin/TCF4 signalling in a subset of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T J Pathol; 2010 Dec; 222(4):410-20. PubMed ID: 20922712 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231 [TBL] [Abstract][Full Text] [Related]
20. A functional role of Cdx2 in beta-catenin signaling during transdifferentiation in endometrial carcinomas. Saegusa M; Hashimura M; Kuwata T; Hamano M; Wani Y; Okayasu I Carcinogenesis; 2007 Sep; 28(9):1885-92. PubMed ID: 17468517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]